Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation

BACKGROUND AND PURPOSE—: Once a patient with atrial fibrillation experiences an embolic event, the risk of a recurrent event increases 2.6-fold. New treatments have emerged as viable treatment alternatives to warfarin for stroke risk reduction in secondary prevention populations. This analysis sough...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Reddy, Vivek Y., Akehurst, Ronald L., Amorosi, Stacey L., Gavaghan, Meghan B., Hertz, Deanna S., Holmes, David R.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2018
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5976225/
https://ncbi.nlm.nih.gov/pubmed/29739915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.018825
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars